Evaluation of IGF۲, KRT۱۴, and KRT۲۰ as Urinary Biomarkers in Patients with Bladder Cancer
- سال انتشار: 1401
- محل انتشار: مجله گزارش های بیوشیمی و زیست شناسی مولکولی، دوره: 11، شماره: 4
- کد COI اختصاصی: JR_RBMB-11-4_018
- زبان مقاله: انگلیسی
- تعداد مشاهده: 151
نویسندگان
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Department of Urology, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran.
Shariati Hospital, Alborz University of Medical Sciences, Karaj, Iran.
Department of Pathobiology, School of Medicine, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran.
Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran & BESTforPM (Biomarker Evaluation and Supervision Team for Personalized Medicine), Imam Khomeini Hospital Complex, Tehran Univers
Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
چکیده
Background: Many researchers have tried to identify bladder cancer biomarkers to reduce the need for cystoscopy. The aim of this study was to identify and measure appropriate transcripts in patient urine to develop a non-invasive screening test. Methods: From February ۲۰۲۰ to May ۲۰۲۲, ۴۹ samples were obtained from Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran. Twenty-two samples were obtained from bladder cancer patients and ۲۷ from bladder cancer-free subjects. RNA was extracted from participant samples, quantitative RT-PCR was performed, and TNP plots were used to assess IGF۲ (NCBI Gene ID: ۳۴۸۱), KRT۱۴ (NCBI Gene ID: ۳۸۶۱) and KRT۲۰ (NCBI Gene ID: ۵۴۴۷۴) expression. For UCSC Xena analysis, Dataset ID: TCGA-BLCA was used to compare transitional cell carcinoma (TCC) and normal samples for survival rates. Results: IGF and KRT۱۴ were more greatly expressed in patient urine samples than in those of the normal group. However, KRT۲۰ expression did not significantly differ between the two groups. IGF۲ had ۴۵.۴۵ and ۸۸.۸۹% sensitivity and specificity, respectively, for detecting TCC in urine samples while KRT۱۴ had ۵۹ and ۸۸.۸۹% sensitivity and specificity, respectively. Also, these results infer that overexpression of IGF would be prognosticators of poor TCC outcomes. Conclusions: Our study showed that IGF۲ and KRT۱۴ are overexpressed in bladder cancer patient urine, and IGF۲ could be a potential biomarker for poor prognoses in TCC.کلیدواژه ها
Biomarkers, Diagnosis, Genes, Liquid biopsy, Urinary bladder neoplasms.اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.